Disable ads (and more) with a premium pass for a one time $4.99 payment
The deployment of a specific wavelength laser light in photodynamic therapy (PDT) is primarily intended to induce a photochemical reaction. This process involves the activation of a photosensitizing agent that has been selectively accumulated in diseased tissues, such as neoplastic lesions. When the specific wavelength laser light is applied, it excites the photosensitizer, leading to a series of photochemical reactions that generate cytotoxic singlet oxygen and other reactive oxygen species. These molecules can effectively damage cellular components and lead to tumor cell death while sparing the surrounding healthy tissue, which is a key advantage of this therapy.
Specific wavelength selection is crucial, as it needs to match the absorption characteristics of the photosensitizer to maximize its activation and enhance the therapeutic effect. This precise targeting is what sets PDT apart as a minimally invasive treatment option for certain types of cancer and other conditions, allowing for both tissue preservation and effective treatment response. The effectiveness of this therapy also relies on the ability to confine damage to diseased cells while minimizing the impact on adjacent normal cells.